Page last updated: 2024-10-26

dihydrocytochalasin b and Osteosarcoma

dihydrocytochalasin b has been researched along with Osteosarcoma in 1 studies

dihydrocytochalasin B: inhibits cell motility in many eucaryotic cells

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takeshita, H1
Kusuzaki, K1
Ashihara, T1
Gebhardt, MC1
Mankin, HJ1
Hirasawa, Y1

Other Studies

1 other study available for dihydrocytochalasin b and Osteosarcoma

ArticleYear
Actin organization associated with the expression of multidrug resistant phenotype in osteosarcoma cells and the effect of actin depolymerization on drug resistance.
    Cancer letters, 1998, Apr-10, Volume: 126, Issue:1

    Topics: Actins; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Differentiation; Cyto

1998